Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.30
-0.3500-3.00%
Post-market: 11.300.00000.00%16:15 EDT
Volume:171.68K
Turnover:1.96M
Market Cap:396.26M
PE:-94.17
High:11.73
Open:11.51
Low:11.27
Close:11.65
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.61
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.34
PE(LYR):-33.15

Loading ...

Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Major Issues Report

Form 8-K - Current report